Recently, in the halls of the Mathematical Sciences Research Institute (MSRI) in Berkeley, Calif., a revelation was taking shape.
In Singapore, we have found the best of both worlds.
I slipped into bioinformatics through the back door.
Scientists have established that gene therapy can cause cancer.1 But after more than a decade of clinical experience, formal evidence is mounting that gene therapy can cure cancer as well. The allure has attracted sufficient attention to launch a journal, Cancer Gene Therapy, in 1994. And burgeoning literature documents progress in the field.2 A landmark event late in 2003 was approval of the first such therapy. China's Shenzhen SiBono GenTech now markets an adenoviral vector that expresses wild
Much has been written about a perceived lack of innovation in the pharmaceutical industry, as it relates to productivity.
If you notice all the countries, states, and municipalities actively courting biotech companies, you might think science-based businesses are a surefire guarantee of a strong local economy.
The ability to derive embryonic stem cells from cloned human embryos and to control their differentiation into different cell types provides revolutionary new opportunities in biology and medicine.
The Google search engine has revolutionized knowledge dissemination over the Internet.
Every drug has a story behind it.
This past year President Bush announced a plan for space exploration that includes preparing for a human mission to Mars.